Ceftolozane-tazobactam in combination with fosfomycin for treatment of MDR/XDR P. aeruginosa infective endocarditis-Reference-Cited by-同舟云学术

Ceftolozane-tazobactam in combination with fosfomycin for treatment of MDR/XDR P. aeruginosa infective endocarditis

Published:2019-10 Issue: Volume:2 Page:100011
ISSN:2590-1702
Container-title:Clinical Infection in Practice
language:en
Short-container-title:Clinical Infection in Practice

Author:

Prescott A.,Kennedy S.,Howard P.,Collyns T.,Gilleece M.H.,Pirone F.,Baig M.W.,Donnellan C.,Sandoe J.A.T.

Funder

Pfizer Inc.

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance;Magiorakos;Clin. Microbiol. Infect.,2012

2. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009;Zilberberg;J. Hosp. Med.,2013

3. Antibiotic Resistance Surveillance Group. Antibiotic Resistance Surveillance Group. Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands;Croughs;Eur. J. Clin. Microbiol. Infect. Dis.,2013

4. Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12);Sader;J. Antimicrob. Chemother.,2014

5. Successful treatment of multidrug-resistant Pseudomonas aeruginosa pubic symphysis osteomyelitis with ceftolozane/tazobactam;Kurtzhalts;BMJ Case Rep.,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftolozane/tazobactam for refractory P. aeruginosa endocarditis: A case report and pharmacokinetic analysis;Journal of Infection and Chemotherapy;2022-01